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Differential Associations of Leptin with
Adiposity Across Early Childhood
Caroline E. Boeke1,2,3, Christos S. Mantzoros4, Michael D. Hughes5, Sheryl L. Rifas-Shiman6,
Eduardo Villamor1,2,7, Chloe A. Zera8 and Matthew W. Gillman2,6
Objective: To examine associations of perinatal and 3-year leptin with weight gain and adiposity through
7 years.
Design and Methods: In Project Viva, plasma leptin from mothers at 26-28 weeks’ gestation (n ¼ 893),
umbilical cord vein at delivery (n ¼ 540), and children at 3 years (n ¼ 510) was assessed in relation to
BMI z-score, waist circumference, skinfold thicknesses, and dual X-ray absorptiometry body fat.
Results: 50.1% of children were male and 29.5% non-white. Mean (SD) maternal, cord, and age 3 leptin
concentrations were 22.9 (14.2), 8.8 (6.4), and 1.8 (1.7) ng/ml, respectively, and 3- and 7-year BMI z-
scores were 0.46 (1.00) and 0.35 (0.97), respectively. After adjusting for parental and child characteristics,
higher maternal and cord leptin were associated with less 3-year adiposity. For example, mean 3-year
BMI z-score was 0.5 lower (95% CI: 0.7, 0.2; P-trend ¼ 0.003) among children whose mothers’ leptin
concentrations were in the top versus bottom quintile. In contrast, higher age 3 leptin was associated
with greater weight gain and adiposity through age 7 [e.g., change in BMI z-score from 3 to 7 years was
0.2 units (95% CI: 0.0, 0.4; P-trend ¼0.05)].
Conclusion: Higher perinatal leptin was associated with lower 3-year adiposity, whereas higher age 3
leptin was associated with greater weight gain and adiposity by 7 years.
Obesity (2013) 21, 1430-1437. doi:10.1002/oby.20314
Introduction
The major functions of leptin, a peptide hormone primarily produced
by adipocytes, are to suppress appetite and stimulate metabolism
(1). Research in rodent models suggests a critical period in early life
in which leptin exposure matures hypothalamic neurons responsible
for appetite balance, thereby moderating subsequent energy balance
and the trajectory of weight gain (2). Administering leptin to rats
during late gestation and lactation reduces high-fat-diet-induced
weight gain and insulin resistance in male offspring (3), and neo-
natal leptin treatment reverses the adipogenic effects of prenatal
undernutrition (4). However, later in life, some animals
experience leptin tolerance, which is the inability of higher leptin
concentrations to regulate energy homeostasis; some may use the
terms ‘‘leptin resistance’’ or ‘‘decreased leptin sensitivity.’’ At
that point, the critical window of exposure has closed (5,6). For
example, leptin exposure in the early postnatal period prevented
obesity development in leptin-deficient ob/ob mice, but exposure
later in life did not (7). Leptin tolerance may develop because of
several factors including impaired transport of leptin across the
blood-brain barrier, impaired negative feedback mechanisms, stress
in the endoplasmic reticulum, and a saturable intracellular leptin
signaling system (8-10).
In humans, a period of leptin sensitivity also appears to exist early
in life. The placenta pumps large amounts of leptin into maternal,
and to a lesser extent, fetal circulation, which may act as a stimulus
to maturing fetal appetite and thus appropriate weight regulation
(11). We previously reported that higher leptin in venous umbilical
cord blood at delivery predicts slower child gain in weight-for-
length in the first 6 months of life and lower BMI z-score in 3-year-
old children (12,13); other studies showed similar associations
(14-17). In contrast, in some studies in older children and adoles-
cents, particularly among those who are overweight or obese, higher
leptin predicts greater subsequent weight gain, suggesting tolerance
to leptin’s appetite-regulating effects has already developed (18-20).
For example, in a study of normal-weight and overweight American
children aged 6-12 years, leptin at baseline was associated with
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greater BMI (n ¼ 197) and DXA fat mass (n ¼ 149) after an aver-
age follow-up of 4.4 years (20). In adults, administration of
recombinant leptin does lead to some weight loss, but supra-physio-
logic doses are required and weight loss is not substantial (21). Lep-
tin tolerance appears to be a key factor that makes sustained weight
loss extremely challenging in overweight and obese individuals.
This evidence suggests that perinatal exposure to leptin reduces
appetite and subsequent weight gain, whereas owing to tolerance,
later exposure to leptin does not have the same weight-lowering
effects (Figure 1). No previous study has examined the development
of leptin tolerance longitudinally within the same cohort. The timing
of any reversal in leptin’s effects is unknown, and it is not clear
whether such a reversal is present in normal-weight as well as over-
weight or obese children. Therefore, we examined leptin from moth-
ers during pregnancy, from the umbilical vein at delivery, and from
children at 3 years in relation to child weight gain and adiposity at
ages 3 through 7. On the basis of animal experimental studies and
our previous work, we hypothesized that after adjustment for mater-
nal and fetal adiposity, maternal and cord blood leptin would be
inversely associated with child adiposity, but that by age 3, the lep-
tin-adiposity association would change to a positive direction.
Methods and Procedures
Study population
Participants were from Project Viva, an ongoing prospective cohort
study of pre- and perinatal influences on maternal, fetal, and child
health. In 1999-2002, we recruited pregnant women at in-person vis-
its in the first trimester of pregnancy from eight obstetric offices of
Harvard Vanguard Medical Associations, a multisite group practice
in eastern Massachusetts, as described previously (22). Mother-child
in-person visits occurred at 6 months, 3 years, and 7 years. Annu-
ally, we collected self-reported questionnaire data, and throughout
we obtained other data from medical records. The number of live
births to study participants was 2,128. Of the 2,128 mother-child
pairs, 1,829 had at least one leptin measurement and of those, 1,283
had BMI measurements at ages 3 and/or 7. We excluded one indi-
vidual with implausible maternal leptin values (>100 ng/ml) and
individuals missing any covariate data, leaving 1,063 mother-child
pairs in this analytic sample.
We collected blood samples at in-person study visits conducted with
the mothers at 26-28 weeks’ gestation (n ¼ 893), at delivery from
the umbilical cord (n ¼ 540), and with the children at 3 years (n ¼
510). The analytic samples included 839 mother-child pairs for
maternal leptin and 3-year BMI, 717 for maternal leptin and 7-year
BMI, 508 for cord leptin and 3-year BMI, 421 for cord leptin and
7-year BMI, and 510 for age 3 leptin and 7-year BMI.
Institutional review boards of Harvard Pilgrim Health Care, Brigham
and Women’s Hospital, and Beth Israel Deaconess Medical Center
approved the study protocols and all mothers provided written
informed consent.
Data collection
To measure leptin, we refrigerated nonfasting venous whole blood
samples immediately after collection and transferred them to the
storage laboratory within 24 hours, where they were spun and blood
components were separated into aliquots for storage in liquid nitro-
gen. We measured plasma leptin using an immunoassay (Linco
Research Inc., St Charles, Missouri, USA) as described previously
(23).
Our primary outcome was BMI z-score, but we also included waist
circumference, sum of skinfolds, and DXA fat mass as outcomes.
We obtained birthweight from hospital records. Trained research
assistants measured child length within 2 days after birth and height
at 3 and 7 years as described previously (12), and weight with a
calibrated scale (age 3: Seca model 881, Seca Corp, Hanover,
Maryland; age 7: Tanita model TBF-300A, Tanita Corporation of
America, Inc., Arlington Heights, Illinois, USA). We calculated
birthweight-for-gestational age z-score using national reference data
from the United States Natality datasets (24) and age-sex-adjusted
BMI z-score using the 2000 Centers for Disease Control and Preven-
tion growth charts (25,26).
At ages 3 and 7, trained research assistants measured waist circum-
ference to the nearest 0.1 cm using a Hoechstmass measuring tape
FIGURE 1 Conceptual model of how maternal, fetal, and child leptin affect adiposity in childhood. We hypothesize
that perinatally, leptin acts on appetite-regulating pathways during a period of leptin sensitivity to decrease subse-
quent excess weight gain and adiposity. In contrast, by early childhood leptin tolerance, or reduced leptin sensitivity,
is present, resulting in direct associations of leptin with concurrent and subsequent adiposity. Arrows indicate known
or possible associations. The relative strengths of these associations vary.
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(Hoechstmass Balzer GmbH, Sulzbach, Germany) and subscapular
and triceps skinfolds as described previously (12). We calculated the
sum of the two skinfold thicknesses.
At age 7, research assistants also administered whole body DXA
scans to the children with a Hologic model Discovery A fan-beam
scanner (Hologic, Bedford, Massachusetts, USA) with Hologic soft-
ware QDR version 12.6. A single trained investigator (CEB)
checked all DXA scans for positioning, movement, and artifacts,
and defined body regions to assess whole body fat mass. Intrarater
reliability of 30 scans was high (r ¼ 0.99).
Using questionnaires, interviews, and medical records, we collected
information on sociodemographic factors, lifestyle habits, and medi-
cal and reproductive history from the first trimester through child-
hood as described previously (22). Mothers reported breastfeeding
duration and child behavioral characteristics including television
watching, sugar-sweetened beverage and fast food consumption, and
sleep duration through age 7.
Statistical analysis
After evaluating descriptive data, we conducted multivariable linear
regression to evaluate child adiposity and change in adiposity
according to quintiles of leptin, and calculated P-values for trend
across the quintiles. We assessed maternal and cord leptin individu-
ally in relation to child adiposity at 3 and 7 years as well as change
in adiposity from 3 to 7. We also assessed child age 3 leptin in rela-
tion to adiposity at 7 years and change in adiposity from 3 to 7.
We built models by first examining unadjusted associations; then to
evaluate confounding, we assessed how associations changed when
we added variables we considered a priori as confounders or that were
associated with leptin and/or adiposity individually and/or in small
groups to assess whether magnitudes of association changed. First, we
added maternal prepregnancy BMI and then sequentially added child
BMI at the beginning of the time interval, socioeconomic charac-
teristics, parental health characteristics, and child characteristics. We
present three models: 1) unadjusted, 2) adjusted for baseline BMI
(maternal leptin model: mother’s prepregnancy BMI; cord model:
mother’s prepregnancy BMI and infant birthweight-for-gestational
age z-score; age 3 model: mother’s prepregnancy BMI and age 3 BMI
z-score), and 3) additionally adjusted for other covariates. For models
with waist circumference, skinfolds, or DXA as outcomes, we also
adjusted for child height at the outcome visit. We initially adjusted for
maternal glucose tolerance and child diet, sleep, and television view-
ing as other potential confounders, but including these variables in our
models did not substantially change exposure-outcome associations,
so we did not include them in the final models.
We evaluated effect modification by child sex by including continu-
ous interaction terms. For the analyses with 3-year leptin as the ex-
posure, we additionally evaluated effect modification by attained 3-
year BMI z-score.
We used a complete case approach for all analyses because there
were few missing data for the covariates. We also analyzed the data
using several approaches to multiple imputation that included imput-
ing covariates only as well as covariates, exposures, and outcomes.
Results were consistent with those presented here. We performed all
calculations in SAS version 9.2 (SAS Institute, Inc, Cary, North Car-
olina, USA).
Results
Among the 1,063 children in this analysis, 50.1% were male and
70.5% were white (Table 1). Mean (SD) BMI z-scores at ages 3 and
TABLE 1 Characteristics of the 1,063 participating
maternal-child pairs from Project Viva
Variable N
Mean
(SD)/N (%)
Maternal/paternal characteristics
2nd trimester leptin, ng/mL 893 22.9 (14.2)
Age at enrollment (mean
10 weeks’ gestation), y
1,063 32.6 (4.9)
Prepregnancy BMI, kg/m2 1,063 24.7 (5.2)
Paternal BMI, kg/m2 1,063 26.4 (3.8)
Gestational weight gain, kg 1,063 15.6 (5.3)
Total physical activity in
2nd trimester, hr/wk
950 6.7 (6.3)
Total energy intake in
2nd trimester, kcal/day
962 2,160 (620)
Smoked during pregnancy 1,063 107 (10.1%)
Education level, at least college degree 1,063 776 (73.0%)
Household income, more than $70,000 1,036 687 (66.3%)
Child characteristics
Venous cord blood leptin, ng/mL 540 8.8 (6.4)
Age 3 leptin, ng/mL 604 1.8 (1.7)
Birthweight, g 1,062 3,501 (545)
Gestational age at birth, weeks 1,063 39.5 (1.8)
Birthweight-for-gestational-age z-score 1,062 0.23 (0.94)
Breastfeeding duration, mo 1,063 6.4 (4.6)
Age 3 BMI, kg/m2 1,003 16.5 (1.5)
Age 3 BMI z-score 1,003 0.46 (1.00)
Age 3 waist circumference, cm 1,001 51.3 (3.5)
Age 3 SS þ TRa, mm 970 16.7 (4.1)
Age 7 BMI, kg/m2 860 17.0 (2.7)
Age 7 BMI z-score 860 0.35 (0.97)
Age 7 DXA fat mass, kg 689 7.1 (3.4)
Age 7 waist circumference, cm 860 59.4 (7.8)
Age 7 SS þ TRa, mm 859 19.3 (9.6)
Change in BMI z-score between
ages 3 and 7
800 -0.1 (0.8)
Change in waist circumference
between ages 3 and 7, cm
803 8.1 (6.2)
Change in SS þ TRa between
ages 3 and 7, mm
779 2.3 (7.5)
Male sex 1,063 532 (50.1%)
Race/ethnicity
White 1,063 749 (70.5%)
Black 1,063 125 (11.8%)
Hispanic 1,063 41 (3.9%)
Asian 1,063 34 (3.2%)
More than one race/Other 1,063 114 (10.7%)
aSSþTR: sum of subscapular and triceps skinfold thicknesses.
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7 were 0.46 (1.00) and 0.35 (0.97), respectively. Spearman correla-
tion coefficients were 0.10 (P ¼ 0.05) between maternal and cord
blood leptin, 0.06 (P ¼ 0.21) between maternal and age 3 leptin,
and 0.26 (P < 0.0001) between cord blood and age 3 leptin. Com-
pared with the analytic sample, the 1,065 mother-child pairs without
complete exposure, outcome, and covariate data had higher leptin
[mean (SD) for maternal concentration: 23.9 (14.6) vs. 22.9 (14.2);
umbilical cord blood: 9.4 (7.0) vs. 8.8 (6.4); age 3: 2.5 (3.0) vs. 1.8
(1.7) ng/ml]; and mothers with higher prepregnancy BMI [25.1 (6.0)
vs. 24.7 (5.2) kg/m2], younger age [31.1 (5.4) vs. 32.6 (4.9) years],
greater smoking during pregnancy (16.0% vs. 10.1%), less education
(56.1% vs. 73.0% with college degree or higher), and lower house-
hold income (54.8% vs. 66.3% with income more than $70,000).
However, paternal BMI, maternal gestational weight gain, and child
birthweight-for-gestational age z-score were similar in the two groups.
In unadjusted models, higher maternal and age 3 leptin, but not cord
leptin, were associated with greater child BMI z-score (Table 2).
However, adjusting for maternal prepregnancy BMI and child birth-
weight-for-gestational age z-score revealed inverse associations of
maternal and cord leptin with child BMI z-score. In comparison,
adjusting for sociodemographic characteristics changed associations
less. Adjusting for child 3-year BMI z-score attenuated the positive
association between age 3 leptin and BMI z-score at age 7. The
adjusted difference for the comparison of highest versus lowest
quintile of age 3 leptin changed from 0.5 (95% CI: 0.2, 0.7; P-trend
< 0.0001 across quintiles) when adjusted only for maternal BMI to
0.2 (95% CI: 0.0, 0.4; P-trend ¼ 0.04) when additionally adjusted
for child BMI z-score.
In fully adjusted models, higher maternal leptin and cord leptin were
associated with lower 3-year BMI z-score, waist circumference, and
sum of skinfolds, with the exception of maternal leptin and sum of
skinfolds (Tables 2 and 3). For example, second trimester maternal
leptin in the highest (vs. lowest) quintile was associated with child
BMI z-scores 0.5 units lower (95% CI: 0.7, 0.2; P-trend ¼ 0.003
across quintiles; Figure 2). At age 7, results were suggestive of a simi-
lar inverse association but less consistent. Maternal and cord blood
leptin were each inversely associated with 7-year BMI z-score [e.g.,
0.4 units lower (95% CI: 0.6, 0.1; P-trend ¼ 0.01) for highest ver-
sus lowest quintile of maternal leptin] but were not consistently asso-
ciated with waist circumference, DXA fat, or sum of skinfolds at age
7, or change in adiposity from ages 3 to 7 (Table 3).
In multivariable models, higher age 3 leptin was associated with
increased adiposity by age 7 as measured by BMI z-score, waist cir-
cumference, sum of skinfolds, and DXA. For example, children in
the highest (vs. lowest) quintile of 3-year leptin had higher mean
BMI z-score (0.2 units [95% CI: 0.0, 0.4; P-trend ¼ 0.05]; Figure
2), waist circumference [2.0 cm (95% CI: 0.6, 3.5; P-trend ¼
0.004)], sum of skinfolds [4.5 mm (95% CI: 2.5, 6.4, P-trend <
0.0001)], and DXA fat mass [1.6 kg (95% CI: 0.9, 2.3; P-trend <
0.0001)]. Higher 3-year leptin was also associated with greater
change in adiposity between ages 3 and 7. For example, change in
BMI z-score from 3 to 7 years was 0.2 kg/m2 higher (95% CI:
0.0, 0.4; P-trend ¼ 0.05) among children whose 3-year leptin con-
centrations were in the top versus bottom quintile.
Results were similar when we restricted the analysis to those with
data on all three leptin measurements, BMI at ages 3 and 7, and all
covariates (n ¼ 183).
We did not observe effect modification by sex (e.g., interaction P ¼
0.70 for maternal leptin and 3-year BMI z-score) or modification of
the associations of 3-year leptin with 7-year adiposity (or with
change in adiposity from 3 to 7) by child BMI z-score at age 3
(e.g., interaction P ¼ 0.28 for outcome of BMI z-score at age 7).
Discussion
Among mother-child pairs in a single cohort study, we found that
higher maternal second trimester and venous umbilical cord blood
leptin concentrations were associated with less adiposity at 3 years,
whereas higher age 3 leptin was associated with greater weight gain
and adiposity through age 7. This study extends our previous finding
that high cord blood leptin predicts lower initial weight gain and
adiposity. Most importantly, we found a positive association
between age 3 leptin and weight gain and adiposity through age 7.
This finding supports our hypothesis of a critical perinatal period of
leptin sensitivity followed by reduced leptin sensitivity in early
childhood.
Although we could not measure it directly, we used epidemiologic
methods to estimate fetal exposure to leptin in mid- and late-
pregnancy. By adjusting for maternal BMI and birthweight-for-ges-
tational age, we sought to assess leptin exposure independent of
concurrent maternal or fetal adiposity, which could be related to
child adiposity through other mechanisms. For this reason, although
the unadjusted associations between maternal leptin and child BMI
z-score were positive, adjustment for maternal fat mass rendered the
associations inverse. Analogously, cord leptin was not associated
with child 3- and 7-year BMI z-score in unadjusted models, but
adjustment for maternal and infant fat mass caused that association
to be inverse. We speculate that the placenta plays an important role
in fetal leptin exposure. Together with the concordance of results for
maternal and cord leptin, our findings suggest that the observed
inverse associations between perinatal leptin and child adiposity are
largely from fetal leptin exposure, and that associations are consist-
ent in mid- to late-pregnancy.
Our finding that maternal and cord blood leptin was inversely asso-
ciated with child 3-year adiposity extends our previous findings in
the same cohort that higher cord blood leptin is associated with
smaller change in weight-for-height from birth through 6 months
and lower BMI z-score at age 3. (12, 13) Our cord blood findings
are consistent with results in other cohorts in infants through adoles-
cents. (14-17) For example, in a study of 197 infants in the United
Kingdom, higher cord blood leptin was associated with less rapid
weight gain from birth through 24 months (15).
Leptin at 3 years was positively associated with weight gain over
the ensuing four years, a novel finding in such a young age group.
Adjustment for 3-year BMI z-score attenuated the association
between age 3 leptin and age 7 adiposity, indicating that the unad-
justed association was driven, at least in part, by baseline adiposity.
However, even after adjustment, a positive association between lep-
tin and adiposity was present. This finding suggests tolerance to lep-
tin’s weight-regulating effects, which is supported by intervention
studies showing that leptin administration to overweight and obese
individuals has little to no effect on adiposity (21, 27-29). However,
individuals with congenital leptin deficiency gain weight rapidly and
become obese, but return to normal weight when administered
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exogenous leptin, suggesting that leptin itself is necessary to pro-
duce leptin tolerance (30,31). The children in our study were
younger than those in previous studies that found a positive associa-
tion between leptin and weight gain (18-20), and were largely of
normal weight. Together with our findings of no effect modification
by BMI, these findings suggest that leptin tolerance begins in the
first 3 years of life and applies to children with both normal and
high BMI z-scores. However, two previous studies in healthy groups
of children and adolescents older than ours (>6 years old at base-
line) found that leptin was inversely associated with weight gain
(16,17). One possible explanation for the different findings is that
those studies did not fully adjust for potential confounders of the
associations of leptin with adiposity. In addition, leptin concentra-
tions and sensitivity may change during puberty, and they may vary
across populations with a different make-up of social, ethnic, and
adiposity characteristics.
Our findings are also consistent with animal research suggesting
early-life programming of leptin sensitivity but later leptin insensitiv-
ity (3,4,7). Yuen et al. (32) reported that infusion of leptin into the fe-
tal sheep circulation caused changes in lipid storage characteristics
and leptin synthetic capacity. Leptin administration to male rats from
postnatal days 3-13 slowed weight gain in those that were undernour-
ished in utero, and increased weight gain in those that were
adequately nourished (33). Neonatal leptin administration effectively
abolished the lifetime dysmetabolism otherwise caused by exposing a
pregnant dam to a low-energy diet (33). However, other studies in
rodents found evidence of decreased leptin sensitivity during adult-
hood. For example, rats that were undernourished during gestation
did not lose weight when administered leptin as adults (6), and obese
mice lost less weight than lean mice when administered leptin (5).
Early postnatal leptin exposure prevented obesity development in lep-
tin-deficient ob/ob mice, but later exposure did not (7).
A period of leptin sensitivity followed by leptin tolerance has impor-
tant implications for obesity prevention. Leptin production during
gestation may be sensitive to external influences, in turn program-
ming the child’s neural circuitry to determine later appetite and
metabolism. Our study suggests that leptin exposure in the perinatal
period may affect child metabolism and satiety signals, in turn raising
the possibility that interventions to alter leptin physiology early in
human development may have lasting effects on obesity prevention.
To mount preventive interventions targeting leptin physiology, more
information about modifiable determinants of perinatal leptin is
needed. Maternal over- or under-nutrition during pregnancy affected
adipose leptin mRNA and plasma leptin concentration in sheep (34),
and diabetes in pregnant mouse dams impaired leptin sensitivity in
their offspring (35). We previously found in Project Viva that mater-
nal energy intake and diet patterns during pregnancy were not asso-
ciated with cord leptin, but that higher protein intake was weakly
associated with lower cord leptin (36).
The strengths of this study include prospectively measured exposure
and outcome data, careful control of confounders, and measurement
of exposures and outcomes at multiple time points in early life,
allowing for observation of changes in leptin sensitivity over time.
This study has several limitations. We did not have access to tissue
from the placenta, so we could not directly examine placental leptin
in relation to child adiposity. Nevertheless, we obtained cord bloodT
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from the umbilical vein, which drains the placenta. Another limita-
tion is that, as in most epidemiologic studies, we did not have
access to frequently sampled leptin to assess the impact of circadian
variation, nor were we able to assess changes in leptin in response
to experimental conditions such as administration of other hormones
(37). Also, owing to the vicissitudes of collecting blood at delivery
and from 3-year-olds, we did not have leptin at all three time points
on all individuals. However, sociodemographic characteristics were
similar among the three study samples, implying that the results at
each time interval should be internally valid. To assess the potential
for bias because of loss to follow-up, we ran analyses using multiply
imputated datasets and results were similar to those presented.
Nevertheless, differences between participants included in this ana-
lytic sample and the rest of the cohort may have introduced some
bias to the analysis. We were unable to directly measure fat mass at
the time of leptin measurement, so there may be some residual con-
founding by body fat. Finally, because this study is observational, it
is important to interpret our findings with caution and compare our
results with whole animal experiments, in vitro studies, and ulti-
mately, randomized controlled trials, to establish causality.
TABLE 3 Multivariable associations of leptin concentrations with adiposity measures at ages 3 and 7 years, and with change
in BMI z-score from 3 to 7 years. Estimates show association for highest versus lowest quintiles of plasma leptin
concentrationa
Exposure
Difference in means: Q5 vs. Q1 (95% CI)
Maternal leptin Cord leptin Child age 3 leptin
Age 3 outcomes
BMI z 0.5 (0.7, 0.2) 0.5 (0.8, 0.2) –
Waist circumference (cm) 1.3 (2.1, 0.5) 1.4 (2.3, 0.4) –
SS þ TRb (mm) 0.8 (1.8, 0.3) 1.4 (2.7, 0.1) –
Age 7 outcomes
BMI z 0.4 (0.6, 0.1) 0.4 (0.7, 0.1) 0.2 (-0.0, 0.4)
Waist circumference (cm) 2.1 (3.8, 0.4) 0.1 (2.0, 2.1) 2.0 (0.6, 3.5)
SS þ TRb (mm) 0.2 (2.1, 2.5) 1.1 (1.5, 3.7) 4.5 (2.5, 6.4)
DXA fat mass (kg) 0.2 (0.7, 1.0) 0.3 (0.7, 1.3) 1.6 (0.9, 2.3)
Change between ages 3 and 7
BMI z 0.1 (0.1, 0.3) 0.1 (0.2, 0.4) 0.2 (-0.0, 0.4)
Waist circumferences (cm) 1.1 (2.7, 0.4) 0.3 (1.5, 2.1) 2.3 (0.9, 3.7)
SS þ TRb (mm) 0.0 (1.9, 1.9) 0.7 (1.6, 3.0) 3.7 (1.8, 5.6)
aData from maternal-child pairs in Project Viva. Covariates are the same as in Model 3 from Table 2. Waist circumference, change in waist circumference, SSþTR, change
in SSþTR, and DXA models additionally adjusted for child height. Change outcomes adjusted for age at both 3 and 7 year visits. Bold indicates p < 0.05.
bSS þ TR: sum of subscapular and triceps skinfold thicknesses.
FIGURE 2 Maternal 2nd trimester leptin concentration in relation to child BMI z-score at age 3 (Panel A; P for trend ¼ 0.01), and child age 3
leptin concentration in relation to child BMI z-score at age 7 (Panel B; P for trend ¼ 0.05). Adjusted for maternal prepregnancy BMI, child
BMI z-score at age 3 (Panel B only), household income; maternal age, education level, smoking status, and gestational weight gain; paternal
BMI; and child sex, race/ethnicity, breastfeeding duration, and exact age at exposure and outcome measurements.
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In conclusion, higher maternal prenatal and cord blood leptin con-
centrations were associated with lower child adiposity at age 3,
whereas leptin at age 3 predicted higher weight gain in the subse-
quent four years. These findings are consistent with the hypothesis
of a perinatal period of leptin sensitivity followed by a subsequent
decrease in leptin sensitivity by age 3. We speculate that leptin tol-
erance, which makes weight loss so difficult in adulthood, may
begin in early childhood, highlighting that interventions to prevent
obesity may be especially effective during early, plastic stages of
human development (38).O
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